P
Prediman K. Shah
Researcher at Cedars-Sinai Medical Center
Publications - 489
Citations - 37845
Prediman K. Shah is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Myocardial infarction & Immune system. The author has an hindex of 90, co-authored 478 publications receiving 35974 citations. Previous affiliations of Prediman K. Shah include Centers for Disease Control and Prevention & University of Utah.
Papers
More filters
Journal ArticleDOI
Coronary Plaque Disruption
TL;DR: This review will explore potential mechanisms responsible for the sudden conversion of a stable atherosclerotic plaque to an unstable and life-threatening atherothrombotic lesion—an event known as plaque fissuring, rupture, or disruption.
Journal ArticleDOI
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
Morteza Naghavi,Peter Libby,Erling Falk,S. Ward Casscells,S. Ward Casscells,Silvio H. Litovsky,Silvio H. Litovsky,John A. Rumberger,Juan J. Badimon,Christodoulos Stefanadis,Pedro R. Moreno,Gerard Pasterkamp,Zahi A. Fayad,Peter Stone,Sergio Waxman,Paolo Raggi,Mohammad Madjid,Mohammad Madjid,Alireza Zarrabi,Alireza Zarrabi,Allen P. Burke,Chun Yuan,Peter J. Fitzgerald,David S. Siscovick,Chris L. de Korte,Masanori Aikawa,K.E. Juhani Airaksinen,Gerd Assmann,Christoph R. Becker,James H. Chesebro,Andrew Farb,Zorina S. Galis,Christopher L. Jackson,Ik-Kyung Jang,Wolfgang Koenig,Robert A. Lodder,Keith L. March,Jasenka Demirovic,Mohamad Navab,Silvia G. Priori,Mark D. Rekhter,Raymond D. Bahr,Scott M. Grundy,Roxana Mehran,Antonio Colombo,Eric Boerwinkle,Christie M. Ballantyne,William Insull,Robert S. Schwartz,Robert A. Vogel,Patrick W. Serruys,Göran K. Hansson,David P. Faxon,Sanjay Kaul,Helmut Drexler,Philip Greenland,James E. Muller,Renu Virmani,Renu Virmani,Paul M. Ridker,Douglas P. Zipes,Prediman K. Shah,James T. Willerson,James T. Willerson +63 more
TL;DR: The term "vulnerable patient" may be more appropriate and is proposed now for the identification of subjects with high likelihood of developing cardiac events in the near future and a quantitative method for cumulative risk assessment of vulnerable patients needs to be developed.
Journal ArticleDOI
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
Gregory G. Schwartz,Anders G. Olsson,Markus Abt,Christie M. Ballantyne,Philip J. Barter,Jochen Brumm,Bernard R. Chaitman,I. Holme,David Kallend,Lawrence A. Leiter,Eran Leitersdorf,John J.V. McMurray,Hardi Mundl,Stephen J. Nicholls,Prediman K. Shah,Jean-Claude Tardif,R. Scott Wright,R. Scott Wright +17 more
TL;DR: In patients who had had a recent acute coronary syndrome, dalcetrapib increased HDL cholesterol levels but did not reduce the risk of recurrent cardiovascular events.
Journal ArticleDOI
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study
Jay N. Cohn,Donald G. Archibald,Susan Ziesche,Joseph A. Franciosa,W. E. Harston,Felix E. Tristani,W. B. Dunkman,William R. Jacobs,Gary S. Francis,K. H. Flohr,Steven A. Goldman,Frederick R. Cobb,Prediman K. Shah,Robert S. Saunders,Robert H. Fletcher,Henry S. Loeb,V. Hughes,Bonnie J. Baker +17 more
Journal ArticleDOI
Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques Implications for Plaque Stabilization
Milita Crisby,Gunilla Nordin-Fredriksson,Prediman K. Shah,Juliana Yano,Jenny Zhu,Jan Nilsson +5 more
TL;DR: Pravastatin decreased lipids, lipid oxidation, inflammation, MMP-2, and cell death and increased TIMP-1 and collagen content in human carotid plaques, confirming its plaque-stabilizing effect in humans.